Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
    • Supplements
    • Publish Supplement
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in
  • My Cart

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • My Cart
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
    • Supplements
    • Publish Supplement
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers

Discover Pediatric Collections on COVID-19 and Racism and Its Effects on Pediatric Health

American Academy of Pediatrics
From the American Academy of PediatricsClinical Report

Practical Approaches to Optimize Adolescent Immunization

Henry H. Bernstein, Joseph A. Bocchini and COMMITTEE ON INFECTIOUS DISEASES
Pediatrics March 2017, 139 (3) e20164187; DOI: https://doi.org/10.1542/peds.2016-4187
Henry H. Bernstein
aDepartment of Pediatrics, Cohen Children's Medical Center of New York, New Hyde Park, New York; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph A. Bocchini Jr
bDepartment of Pediatrics, Louisiana State University Health Sciences Center, Shreveport, Louisiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Comments
Loading
Download PDF

Abstract

With the expansion of the adolescent immunization schedule during the past decade, immunization rates notably vary by vaccine and by state. Addressing barriers to improving adolescent vaccination rates is a priority. Every visit can be viewed as an opportunity to update and complete an adolescent’s immunizations. It is essential to continue to focus and refine the appropriate techniques in approaching the adolescent patient and parent in the office setting. Health care providers must continuously strive to educate their patients and develop skills that can help parents and adolescents overcome vaccine hesitancy. Research on strategies to achieve higher vaccination rates is ongoing, and it is important to increase the knowledge and implementation of these strategies. This clinical report focuses on increasing adherence to the universally recommended vaccines in the annual adolescent immunization schedule of the American Academy of Pediatrics, the American Academy of Family Physicians, the Centers for Disease Control and Prevention, and the American Congress of Obstetricians and Gynecologists. This will be accomplished by (1) examining strategies that heighten confidence in immunizations and address patient and parental concerns to promote adolescent immunization and (2) exploring how best to approach the adolescent and family to improve immunization rates.

  • Abbreviations:
    AAP —
    American Academy of Pediatrics
    AFIX —
    Assessment, Feedback, Incentives, and eXchange (program)
    CDC —
    Centers for Disease Control and Prevention
    HPV —
    human papillomavirus
    MenACWY —
    quadrivalent meningococcal conjugate vaccine
    SBHC —
    school-based health center
    Tdap —
    tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis, adsorbed
  • Introduction

    Immunization is a key preventive cornerstone of pediatric care.1 Current data show a need for improvement in adolescent immunization rates.2 Healthy People 2020 lists 3 adolescent health indicators, which focus on the proportion of adolescents who have (1) well visits, (2) medical insurance, and (3) vaccination coverage.3 Unfortunately, there is a notable downward trend in health care utilization from childhood to early adulthood. One study found that the overall rate for any health care utilization was 88%, 83%, and 72% for 0- through 11-year-olds, 12- through 17-year-olds, and 18- through 25-year-olds, respectively.4 Another study documented that early adolescents (11 through14 years of age) had 3 times more preventive visits than late adolescents.5 Without a consistent source of care, young adults have significantly lower rates of overall health services usage, lower rates of office-based utilization,6 and higher rates of emergency department visits. These trends in health care utilization underscore the importance of the establishment of a longitudinal relationship within a medical home. It has been suggested that the adolescent immunization schedule would draw even more adolescents to the pediatrician’s office, where additional necessary screening and preventive services could be performed.7,8 Familiarity with this information should enable pediatricians to create better implementation strategies to enhance vaccine coverage. An overview of the epidemiology, current recommendations, and barriers associated with the adolescent immunization schedule is discussed in a separate clinical report, “The Need to Optimize Adolescent Immunization” (www.pediatrics.org/cgi/doi/10.1542/peds.2016-4186).

    Physician recommendation and explanation are essential to boosting immunization rates. Yet, strikingly, up to 65% of parents reported not receiving a recommendation from a health care provider for immunizations.9 The major reason for nonreceipt of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis, adsorbed (Tdap), and meningococcal vaccines was lack of health care provider recommendation. In a 2009 survey, 87.9% and 90.6% of parents whose children did not receive the Tdap and meningococcal vaccines, respectively, reported not receiving a recommendation. Nonreceipt of human papillomavirus (HPV) vaccine was associated with a perception that the vaccine was “not necessary.” Similarly, a 2013 study revealed that only 64.4% of parents of girls and 41.6% of parents of boys reported receiving a recommendation for the HPV vaccine from their child’s health care provider.10 Table 1 lists the major reasons for not receiving Tdap, meningococcal, and HPV vaccines. Parents were significantly more likely to report the intention to vaccinate their child if they received a health care provider recommendation, compared with parents who received no provider recommendation (48.9% vs 33.6%; P < .001).

    View this table:
    • View inline
    • View popup
    TABLE 1

    Major Reasons Parents Report Nonreceipt of Tdap, MenACWY, or HPV Vaccines

    The reader is advised to refer to the American Academy of Pediatrics (AAP) Training Guide (​https://shar.es/1JRNmJ) and the Practice Procedure Manual as well as AAP immunization resources (www2.aap.org/immunization/pediatricians/pdf/TopStrategiesforIncreasingCoverage.pdf) for useful resources to help improve immunization rates. In addition, the Centers for Disease Control and Prevention (CDC) lists quality-improvement projects and educational materials for providers (http://www.cdc.gov/vaccines/ed/index.html). The Immunization Action Coalition also has made available a checklist of suggestions to improve immunization rates (“Suggestions to Improve Your Immunization Services”; available at: http://www.immunize.org/catg.d/p2045.pdf). Figure 1 shows the major strategies that can be used to overcome barriers and improve immunization rates in adolescents, which will be discussed in further detail in this report.

    FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    Strategies to overcome barriers to adolescent immunization. (Reprinted with permission from Gowda C, Schaffer SE, Dombkowski KJ, Dempsey AF. Understanding attitudes toward adolescent vaccination and the decision-making dynamic among adolescents, parents and providers. BMC Public Health. 2012;12:509.)

    Strategies for Improving Adolescent Vaccination Rates

    Every encounter should be viewed as a potential opportunity to immunize.2 In a 2010 survey, primary care physicians indicated that they often relied on vaccine-only visits and nurse prompts to identify and address vaccine need. Strategies physicians reported they would consider using, but had not implemented, included patient reminder/recall systems and electronic health record prompts.11,12 Through advancements in electronic health records, providers can set reminders for immunizations and make a patient’s immunization record accessible during any visit.13 Providers can also set up a reminder/recall system, which consists of sending reminders about upcoming recommended vaccines to patients along with recalls that encourage patients who are overdue for vaccines to return to the office for appropriate immunization. These population health management activities have the potential to be powerful and cost-effective tools.

    Overcoming Vaccine Hesitancy

    Vaccine hesitancy in adolescent health care can be challenging to address.14 The AAP has recently published a clinical report that provides information for pediatricians to address vaccine-hesitant parents.14 The following are important approaches that providers should use to increase vaccination rates:

    1. Strongly endorse all universally recommended vaccines as important for adolescents’ health. Offering immunizations as optional opens the door for vaccine dismissal. The health care provider should inform the patient and family about which vaccines are recommended at the current visit. Health care providers also should state the vaccines the adolescent needs without seeming to favor one vaccine over another. Discussion of any concerns or questions can then begin, if needed.

    2. When encountering hesitancy toward a vaccine, answer parents’ questions and concerns and remain unwavering, as medically appropriate. By asking an open-ended question, such as “What concerns do you have?,” the health care provider can allow for better dialogue. Parents who ask questions may not be hesitant; they may be seeking more information. Health care providers should always remember that immunizations are the core of preventive care. It is important to emphasize, “This is my job in helping you care for your child: to inform you of the recommended vaccines and the diseases they prevent, and thereby protect your child the best way we can.”

    3. Focus on the benefits of the vaccine. Educating the patient and family on the diseases that vaccines prevent is key. For example, patients and families are more likely to be receptive if the health care provider informs them and reinforces the fact that HPV vaccine can prevent cancer, that Tdap vaccine can prevent pertussis, and that meningococcal vaccine can prevent meningitis. Up-to-date information on current events and disease outbreaks is a tool to bring into the conversation about vaccines as well. Health care providers also can increase parental confidence and trust in vaccines by mentioning that they give the same vaccines to their families.

    4. Make the family aware of when the vaccines are needed. In addition to informing the family which vaccines the child needs or why they are needed, it is important for the health care provider to review the appropriate timeline for completing the vaccine series. For example, it is important for parents to be aware of the ages when HPV vaccine can be given, when to return for each dose in the series, and the importance of receiving the vaccine before a teenager is likely to be exposed to HPV through sexual activity. Follow-up immunization visits should be scheduled before the family leaves the care setting.

    5. If vaccine refusal occurs, persevere. Although it may be challenging, it is important that health care providers offer the vaccine at the next most appropriate time. Perseverance is critical for vaccine uptake and immunization rates. In the Periodic Survey of Fellows (PS 66) conducted by the AAP in 2006 and a follow-up survey in 2013 (PS 84), pediatricians reported that they were able to convince approximately 30% of parents to vaccinate their children after they initially refused.14 Another observational study found that up to 47% of parents who were initially resistant ultimately accepted vaccines when providers pursued their original recommendations.15 The health care provider should document vaccine discussions and any vaccine refusal (http://www.cdc.gov/vaccines/hcp/patient-ed/conversations/downloads/not-vacc-risks-color-office.pdf). The AAP clinical reports on responding to parental refusals of immunization are useful resources that may assist physicians in overcoming this challenge.14,16

    In further exploring the reasons for vaccine hesitancy, health care providers assess for vaccine readiness and the parents’ position and feelings on vaccines, emphasize the benefits of vaccines, clarify misconceptions, and determine whether there is a lack of understanding or education about a specific vaccine. It is also important to consider the beliefs, misperceptions, and concerns among specific ethnic populations and to be aware that culturally tailored, translated information can help inform strategies to improve adolescent vaccine uptake in these populations.17 Sharing related statistics and educational material can be helpful, but information overload should be avoided. The concept of “chunking and checking” refers to the provision of information in small chunks followed by checking the person’s understanding. This technique contrasts with the common practice of providing much larger amounts of information before checking, which can lead to information overload.18 Although 1 randomized trial did not show an effect of physician-targeted communication interventions on vaccine hesitancy, these suggestions can be helpful, even though their effects are not proven.19 Most important, physicians should avoid confrontation, reflect on and summarize the conversation, and schedule follow-up to reinforce the value of immunization. Table 2 lists helpful and unhelpful strategies in navigating a vaccine discussion.

    View this table:
    • View inline
    • View popup
    TABLE 2

    Unhelpful and Helpful Strategies

    Approaching the Adolescent Patient in the Office Setting

    Adolescents should be encouraged to follow the AAP preventive health care recommendations for routine visits; every visit can be viewed as an opportunity to update and complete an adolescent’s immunizations.2,20 Adolescent health visits are enhanced by fostering and maintaining a relationship with both the parent and the adolescent. Education about adolescent health issues should be a highlight of each encounter. A portion of the adolescent visit should be between the health care provider and the adolescent without the presence of a parent. To the extent permitted by applicable law, confidentiality is important and should be emphasized to all adolescents so they feel more comfortable sharing their perspectives. Health care providers can reduce vaccine hesitancy by establishing rapport and a supportive relationship with patients and by providing appropriate education.21

    Understanding adolescent cognitive development will facilitate the interaction with adolescents and their health care. The adolescent years are a stage in which the mind is developing and adolescents begin to acquire reasoning skills and the ability to think abstractly. Adolescents may not perceive the consequences of risk-taking behavior. They also are in a period in which they seek independence and strive to obtain such independence. It is important to be aware of the aforementioned adolescent framework and to be attuned to the adolescent’s needs during office visits.22

    Motivational interviewing is a strategy that can be used when approaching the adolescent patient and family.23 It is “a collaborative, person-centered form of guiding to elicit and strengthen motivation for change.”24 Motivational interviewing is anticipated to result in changing behavior and encouraging self-reflection. The idea behind motivational interviewing is to allow the patient and parents to come to their own conclusion regarding the importance of and need for immunization. This behavioral change occurs by having the parent reflect on the need to protect the adolescent against preventable diseases (eg, cervical cancer and meningitis). Motivational interviewing can be used to improve vaccine acceptance and overcome hesitancy.

    The core skills used in motivational interviewing include the following:

    • asking open-ended questions,

    • affirming the patient’s efforts and strengths,

    • being a reflective listener, and

    • assessing readiness to change.

    Approaching the Parent in the Office Setting

    To optimize adolescent immunization, it is necessary to understand the range of parental attitudes toward vaccines. By doing so, providers are then able to address potential dilemmas. Approximately 40% of initially vaccine-hesitant parents stated that health care provider information and reassurance were major reasons why they changed their mind.21 Table 3 lists Halperin’s 8-step approach in responding to parents when encountering vaccine hesitancy.25 The best approach to handling vaccine-hesitant parents requires understanding the common reasons for vaccine hesitancy and recognizing the types of vaccine-hesitant parents. This knowledge will then enable the health care provider to navigate and direct the vaccine conversation down different paths depending on the type of hesitancy that is being encountered.

    View this table:
    • View inline
    • View popup
    TABLE 3

    Approaches for Responding to Parents Unsure About Immunization

    There have been attempts to classify the different types of parental positions toward vaccines.26–28 The following is a summary of the different parental positions (Table 4):

    View this table:
    • View inline
    • View popup
    TABLE 4

    Summary of Parental Attitudes

    1. The parent who accepts, does not question, and may be uninformed, but is open to education on vaccines,25 is considered to be the unquestioning acceptor18 or the immunization advocate.26 These parents may have previously heard about reasons not to immunize but are information seekers and want to hear the counter-argument from a vaccine-supporting health care provider.25

    2. The well-informed parent who is open-minded. These parents have a fair amount of knowledge and are considered to be “well read” regarding vaccine issues.25 These parents are willing to vaccinate with the appropriate information and facts. Discussing the risks and benefits thoroughly is necessary to enable vaccine acceptance. Parents may often have “phased agreement to immunization,” meaning that they accept more vaccines over time.25

    3. The parent who is the cautious acceptor is willing to vaccinate despite their awareness of the rare adverse effect profile of vaccines.25

    4. The misinformed parent who is open to education and, with the appropriate information, is willing to vaccinate.25 These parents have some degree of misinformation from the Internet or media, family, or friends and can be “resistant” to dismiss their originally held beliefs but tend to be “correctable” and open to change.25

    5. The vaccine-hesitant parent has significant concerns about the risks of vaccination. It is important for the health care provider to establish rapport and trust while providing information and answering questions. The parent may not be readily open to vaccine acceptance. This parent may also be viewed as the late or selective vaccinator. This group of parents may “delay or select only some recommended vaccines.”18

    6. The vaccine refuser is the parent who entirely refuses all vaccines because of either philosophical or religious beliefs.18 These parents can also be described as “convinced and content” with their belief that immunization is not beneficial, but rather harmful.25 Parents can also be strong opponents of vaccination and “not appreciate the value of immunization.”25

    Strategies aimed toward the diverse parental positions include the following (Table 4):

    1. Building rapport and having brief discussions explaining the benefits and risks of vaccines to the parent who is an unquestioning acceptor or a cautious acceptor.

    2. Relying on a “guiding style” when approaching the vaccine-hesitant parent, which refers to having a helping attitude by (a) seeking permission to discuss immunization, (b) addressing concerns, (c) giving appropriate resources, and (d) determining readiness to change. Motivational interviewing can be used here. Providing detailed and up-to-date information on risks and benefits of vaccines is crucial. Furthermore, scheduling an appointment to further discuss the opportunity for immunization at a later visit is ideal.

    3. Addressing concerns and willingness to change while using motivational interviewing may be a strategy to approach the vaccine refuser.

    The use of nonstandard schedules is a common issue when encountering the vaccine-hesitant parent. It is important to work with these parents to make it more likely that immunizations are given at the appropriate time. It is recommended that health care providers explain that the national vaccine schedule protects children, adolescents, and adults against diseases at the youngest age at which a given vaccine’s safety and effectiveness have been shown. The national schedule has been studied for safety and effectiveness, but nonstandard schedules have not been examined.29

    Health care providers must establish a way to document parental refusal of vaccines or requests for a nonstandard schedule. The AAP Refusal to Vaccinate Form may be used as a template to document discussion with the parent about the risks of failing to immunize the child (https://www.aap.org/en-us/Documents/immunization_refusaltovaccinate.pdf). Health care providers can also create a manual of resources to better address the vaccine-hesitant parent (see Supplemental Information).

    Advocating for HPV Immunization

    It is important to highlight all of the universally recommended vaccines in the adolescent immunization schedule, rates of which vary by vaccine. Indeed, because of various unique barriers, HPV vaccine immunization rates have lagged notably behind those of Tdap and meningococcal vaccines.30 Therefore, the following is a summary of how to approach HPV vaccination and navigate the encounter (see Supplemental Information):

    • Emphasize that HPV immunization prevents cancer. This is a major reason that parents accept the vaccine.

    • Discuss the vaccine schedule with parents, particularly the dosing schedule and the ages of administration. In October 2016, a 2-dose schedule for 9-valent HPV was approved by the Advisory Committee on Immunization Practices for individuals 9 through 14 years of age.31 In a 2014 study by Perkins et al,32 13% of parents reported that they thought their daughters were “too young” for the vaccine. Health care providers should instead emphasize that it is preferable to deliver the vaccine at a younger age, especially because this elicits a better immune response. Similarly, in a study of over 1500 participants, Iversen et al33 found that geometric mean antibody titers against all HPV types in the 9-valent HPV vaccine were higher in the 9- through 14-year-old age groups than in the 16- through 26-year-old female adolescents and women. On the basis of these data, the HPV vaccine may potentially be recommended for individuals younger than 11 or 12 years of age in the future. The new dosing schedule also provides added flexibility and incentive because individuals younger than 15 years require only 2 shots compared with individuals older than 15 years who need 3 shots.

    • Do not delay vaccination, because this can be detrimental. A recent study cohort showed that both providers and parents tended to delay HPV vaccine until there was a sign that the adolescent was approaching sexual activity. However, attempting to predict when the adolescent will become sexually active is difficult and impractical. In addition, it was noted that actual immunization might not occur at a later time as was previously negotiated between the parents and the health care provider.32 Adolescents are less likely than other patients to follow up. Therefore, health care providers should view the current encounter with a “now or never” mentality when framing their efforts toward immunizing adolescents.

    • Coadminister the HPV vaccine with other vaccines, because this can boost HPV immunization rates. Recommending all the adolescent vaccines at the same time increases adherence to the immunization schedule. It is also more practical to give all vaccines at once, because adolescent patients often do not return for medical care and fail to follow up. Adolescents tend to have low rates of immunization, and health care providers are known to overestimate immunization rates.32

    • State that HPV vaccine is part of the routine immunization schedule. A presumptive delivery strategy is an effective communication approach in which providers present vaccine recommendations as required immunizations to maintain optimal disease prevention. In a randomized clinical trial of 29 pediatric and family medicine clinics in North Carolina, Brewer et al found that practices trained in the presumptive delivery stratedgy exhibited a significant increase in HPV vaccine coverage for individuals 11 or 12 years of age when compared with the control group that did not receive any additional training. In contrast, a conversational delivery strategy did not exhibit a significant increase when compared with control.34 The presumptive approach may work well with some parents, however, and pediatricians may use it selectively based on their experience.14 It is important to overcome the concept that the HPV vaccine is optional. Hull et al demonstrated that mothers and daughters were more receptive to discussion of the HPV vaccine as a routine vaccine that prevents cancer.35

    • Clarify the misconception that HPV vaccine can promote promiscuity, if that is a parental concern.

    • Emphasize that HPV vaccine is a safe vaccine. Approximately 200 million doses have been distributed worldwide between 2006 and 2015,36 and no serious adverse outcome has been associated with HPV vaccine.10 The safety of HPV vaccine continues to be monitored through the CDC Vaccine Safety Datalink and the US Food and Drug Administration PRISM programs. The AAP HPV Vaccine Talking Points provides additional information concerning vaccine safety (https://www.aap.org/en-us/my-aap/advocacy/workingwiththemedia/speaking-tips/Pages/HPV-Vaccine.aspx?nfstatus=200&nftoken=177fa0a9-08ac-4bef-ac1d-a5f52c96bd0f&nfstatusdescription=Set+the+cookie+token).

    Table 5 lists successful techniques in advocating for HPV immunization.

    View this table:
    • View inline
    • View popup
    TABLE 5

    Successful Techniques in Advocating for HPV Vaccine

    Reducing Missed Opportunities

    Missed opportunities for adolescent immunizations are relatively common. Therefore, strategies to reduce missed opportunities are key in improving immunization rates. A retrospective study that reviewed electronic health records showed that there was a significant percentage of missed opportunities for immunization: 82% for meningococcal vaccine, 85% for Tdap, and 82% for the first dose of HPV vaccine. The majority of visits that were considered to have a missed opportunity were sick visits or nonpreventive visits.37 Furthermore, health care providers are more attuned to vaccinating younger adolescents than their older counterparts.38

    Most health care visits should be viewed as opportunities to review immunization records, provide vaccines that are due, and catch up on missed vaccinations. The concomitant administration of vaccines, when appropriate, is key to reducing missed vaccination opportunities. For example, in youth with special health care needs, vaccine coverage may be lacking, so concomitant administration of adolescent vaccines could reduce missed opportunities for this vulnerable population.39 The majority of vaccines are administered during well-child visits (eg, sports or camp physicals), and several surveys have shown that health care providers do routinely assess immunization status during such visits.40 However, acute care visits or sick visits in the patient-centered medical home are also an opportunity to deliver vaccines or to discuss upcoming vaccines.41 Assessing immunization status during sick and acute care visits is important. The Immunization Action Coalition has a valuable parent questionnaire entitled “Screening Checklist for Contraindications to Vaccines for Children and Teens.” It is feasible for this checklist to be routinely used in the office setting during both well and sick visits. The CDC also has an online quiz for adolescents entitled “What vaccines do you need?,” which is based on 8 questions that yield a list of vaccines the patient should receive when submitted.

    The CDC Web site provides guidance on how to display immunization schedules onto a clinic’s Web site, which can serve as a helpful resource for providers, patients, and families (http://www.cdc.gov/vaccines/schedules/syndicate.html#easy-read). In addition, the CDC now has an available application for mobile devices entitled “CDC Vaccine Schedule.” The CDC Web site includes a tool for parents and providers to use to look up school immunization requirements. The AAP immunization Web site includes information for providers about case studies on vaccine hesitancy, resources for communicating with families, immunization technology, and vaccine financing, supply, and ordering (https://www.aap.org/en-us/advocacy-and-policy/aap-health-initiatives/immunization/Pages/default.aspx). Health care providers should promote these resources among their patients and patients’ families.

    The College Physicians of Philadelphia has created a Web site on the history of vaccines, which provides many interactive learning tools on vaccines (historyofvaccines.org) and covers the history of antivaccination movements, with a focus on measles-mumps-rubella, the use of thimerosal, and autism. This information can help decrease parental vaccine refusal.

    Using Office-Based Technology

    Prompts for Health Care Providers

    Health care provider prompts are a useful and effective way to reduce missed opportunities in vaccine delivery.42–44 Prompts can be electronic, paper-based, or generated by immunization information systems (previously known as “registries”). The health care provider will see the prompt and then identify whether the adolescent is a candidate for immunization. If the patient is a candidate, the health care provider should then offer the indicated vaccine(s). It is important for electronic health records to incorporate the recommendations of the harmonized immunization schedule of the AAP, the American Academy of Family Physicians, and the CDC.

    It is also important to establish continuity and to enable an adolescent to return for a subsequent vaccine dose. This result can be accomplished by direct communication regarding when the subsequent vaccine dose is needed, scheduling a follow-up visit for immunization during the current visit, and providing an after-visit summary to the patient and parent to serve as a reminder of when to return.

    Prompts for Patients

    Bright Futures handouts can be used in the waiting area or in the examination room to emphasize the value of immunizations in health promotion and disease prevention. The use of tablet computers in the waiting area also has been found to be effective in providing vaccine information to parents, although meaningful engagement with the material was low.45 Vaccine Information Statements from the CDC can be incorporated on a day-to-day basis in the office setting as well. Pediatric offices should also make use of immunization information systems, because they can offer prompts regarding delayed immunization or whether a certain vaccine is indicated. The use of multiple prompts will maximize vaccine delivery. Another important way to improve vaccine delivery is by educating all staff members on the recommended immunization schedule.

    It is helpful for the pediatric office to have access to the adolescent’s daily schedule (ie, being attuned to school hours, extracurricular activities, and work hours) and arrange appropriate office hours. Setting up exclusive immunization clinic days or hours is another strategy that can be incorporated.46

    Reminder/Recall Systems for Patients

    Electronic health records and immunization information systems have the capability of running reports listing patients who are due or overdue for immunizations. Delivering reminders via phone call, text, or mail can be a useful way of targeting patients.47 In a managed care organization serving publicly insured patients, adolescents 11 through 17 years of age who received reminders either by mail or telephone had greater immunization rates for quadrivalent meningococcal conjugate vaccine (MenACWY), Tdap, and HPV vaccine compared with adolescents who received no intervention. For adolescents who were not caught up with vaccinations at the start of the study, uptake significantly increased by 21% for mail-reminder groups and by 17% for telephone-reminder groups versus only 13% for control groups.48 A study on HPV vaccination rates, conducted in managed care organizations, found that text message reminders had a modest effect on HPV dose 1 rates for those who were able to receive the text message with valid phone numbers in the database.49 In another study, postal mail, e-mail, or text reminders were used to improve adolescent vaccination rates. All 3 reminder interventions were effective in improving adolescent vaccination rates. Although postal mail reminders were preferred by most parent participants, text messaging and e-mail were the more effective reminder methods.50

    In a randomized controlled trial targeting low-income adolescents living in urban neighborhoods, a text-messaging intervention compared with usual care was associated with an increased rate of influenza vaccination.51 Matheson et al52 showed that 14% of adolescents and young adults who received text message reminders for their second and third HPV vaccine doses completed the vaccine series at the optimal time, compared with 3% who did not receive the intervention. The study also showed patient and parent support and eagerness for text message reminders. Both adolescents and parents reported that they had easy access to phones, preferred text messages, and found it convenient to communicate via phone.

    Another successful way of boosting immunization rates was shown by using an immunization navigator intervention in a notable study, which entailed (1) a patient tracking database, (2) a reminder/recall system, and (3) home visits.53 The patient tracking database allowed the entry of immunizations and well visits for adolescent patients. Staff members would engage in the reminder/recall system by calling families and mailing letters to notify them about upcoming vaccines and well visits. In addition, transportation would be facilitated. If this measure failed, then the final step would be to approach the patient and family via home visits. The overall immunization rate with the use of this intervention was 44.7% compared with 32.4% for the control group. Preventive care visits also increased among the intervention group compared with the control group: 68% versus 55.2%, respectively.53 Another method of facilitating vaccine delivery is encouraging providers to schedule all follow-up vaccine appointments to complete a vaccine series, such as that required for HPV vaccine.38

    Extending Care Into School-Based Settings

    The use of schools as a pathway to educate and vaccinate adolescents could be helpful to increasing immunization rates. Other vaccination sites that can facilitate immunizing adolescents include pharmacies, mobile vans, clinics for substance abuse or obstetrics/gynecology care, and shelters. Electronic recall/reminder systems may also be used in these alternative vaccination sites. However, all vaccinations in any setting should be documented within the state’s electronic immunization information system.

    The School as an Alternative Vaccination Site

    School-based sites for vaccine administration offer additional ways of providing preventive care to adolescents54–57 and aid in overcoming barriers to access of health care. Models for delivering immunizations in schools include 3 strategies:

    • School-based health centers

    Although some school-based health centers (SBHCs) can meet the definition of the medical home for their patients, SBHCs, in the context of this clinical report, are being used to improve adolescents’ health by helping to ensure that recommended vaccines are received.58 The school venue is also capable of being a primary source of health education.59 A better link between the health and educational departments should be fostered. Schools and health departments should offer routine immunizations at minimal expense to the patient, which can benefit individuals with financial barriers. In turn, schools administering vaccines should communicate with primary care clinics with regard to immunizations given. If an adolescent receives a vaccine outside of his or her medical home, such as at an SBHC, appropriate documentation of immunization should be provided to the adolescent for his or her medical home and entered into the state immunization registry, where possible. The CDC provides a vaccine administration template letter that providers can use (http://www.cdc.gov/flu/school/school_located_vac.htm).

    A retrospective study comparing community health centers and SBHCs of the Denver Health System revealed that SBHCs had significantly higher completion rates for the following immunizations in adolescents 12 to 18 years of age54: hepatitis B (93% vs 84%), Tdap (71% vs 62%), varicella (20% vs 13%), measles-mumps-rubella (89% vs 83%), HPV vaccine for patients aged 16 through 18 years (18% vs 12%), and the HPV vaccine/Tdap/MenACWY immunization series for female patients aged 16 through 18 years (17% vs 11%).54 It has also been shown that adolescents who visit SBHCs are more likely to complete the hepatitis B immunization series compared with adolescents who visit hospital-based health centers.60 SBHCs may represent one means of expanding access to adolescents for vaccinations, and they may serve as a “safety net” for adolescents who do not have reliable access to a medical home elsewhere.57 Almost two-thirds of juniors in high school who completed a survey about vaccination outside the traditional medical home believe that SBHCs are definitely or probably acceptable locations for vaccinations.61

    Several surveys have reported that most parents accept the use of SBHCs to provide immunizations. Although most parents (78%) preferred a doctor’s office for adolescent vaccination, a majority were also definitely or probably accepting of vaccination in public health clinics (74%), school health clinics (70%), obstetrics and gynecology clinics (69%), and emergency departments (67%).62 Surveys of adolescents have also shown that adolescents feel comfortable seeking health care at school,63 which is especially relevant, because many pediatric patients do not rely on a medical home for care. The socioeconomic factors that are linked with these patients are as follows: low-income status, lower educational level, Hispanic ethnicity, residence in the western United States, and speaking a language other than English.64,65

    • Partnering with local practitioners, community clinics, or other community organizations

    Although many schools do not have SBHCs, another model for providing school-located vaccination is partnering schools with public health departments to identify underimmunized adolescents and provide needed vaccines. One study in North Carolina examined the partnership between the school system and the local health department to deliver the HPV vaccine in school-located vaccination clinics. Although HPV vaccine initiation rates among middle school girls did not reach study goals, the involvement of the local health department was key to the success of the school-located vaccination clinic, especially when the school did not have a health center, and the location of the clinic at the host school also increased vaccination rates.66 Another collaboration between Denver Public Schools and Denver Public Health produced a school-located vaccination program in the 2009–2010 and 2010–2011 school years at 27 elementary and middle schools. The vaccination program successfully increased the proportion of enrolled students who received at least 1 dose of vaccine between the first and second years of the program (elementary school: 28%–31%; middle school: 12%–19%).67 Billing and reimbursement can be an issue in school-located vaccination programs, but an alternate study in Denver Public Schools found that billing is feasible, and the program increased the likelihood of receipt of Tdap, MenACWY, and HPV vaccines in adolescents.68 Another program in Florida similarly found that school-located influenza vaccination programs can be economically sustainable by targeting adequate numbers of privately insured children and reducing costs through volunteers and mass vaccination.69

    • School nurses

    School nurses who are part of a school health program that is enrolled as a Vaccines ForChildren program provider play an integral role in achieving and maintaining high coverage of adolescent immunizations.70 They can be valuable resources for delivering vaccines because of their knowledge of the school and its students, and access to immunization information systems may help increase their ability to provide vaccines to adolescent students.71 However, school nurses also hold many responsibilities and may not have the time to participate in school-located vaccine programs because of competing job obligations.72

    School Vaccination Requirements

    It has been shown in the past that immunization requirements can help increase vaccination rates for some vaccines.73,74 Almost all 50 states have implemented immunization requirements for middle school entry, with wide variation. States with vaccine requirements for tetanus-diphtheria (Td)/Tdap and/or MenACWY had significantly higher immunization rates for the respective vaccines compared with states with no vaccination requirements.75,76 Importantly, school entry immunization requirements have also been shown to increase the immunization rates of other vaccines not included in the mandate. For example, states with school entry immunization requirements for Tdap vaccination witnessed approximately a 5% increase in the HPV vaccination rate.77 For more information, the CDC provides a Web site to obtain information on school immunization requirements categorized by child care, kindergarten, middle school, and college/university (http://www2a.cdc.gov/nip/schoolsurv/schImmRqmt.asp). The Immunization Action Coalition also tracks school requirements (http://www.immunize.org/laws/).

    The Role of AAP Chapters and the CDC

    The CDC and the AAP, including its national and state chapters, have played active roles in helping health care providers boost immunization rates locally, regionally, and nationally. A recent CDC report highlighted that HPV immunization rates have increased for ≥1 or ≥3 doses among females in 7 public health jurisdictions: Illinois, Chicago, District of Columbia, Georgia, Montana, North Carolina, and Utah.78 Four of these jurisdictions received resources in 2013 through the Prevention and Public Health Fund from the CDC to improve HPV vaccination coverage. In addition, the Advisory Committee on Immunization Practices’ recommendation to change from a 3-dose to a 2-dose series for persons aged 9 through 14 years is also expected to improve series completion rates.31 In the District of Columbia, school requirements for HPV vaccination were expanded to include males and females through 12th grade.10 The CDC has launched a useful Web site for health care providers (http://www.cdc.gov/hpv/hcp/index.html), including an important handout entitled “Tips and Time-savers for Talking With Parents About HPV Vaccine.” The CDC recently released a 5-year grant, “Improving Immunization and Enhancing Disease Prevention Through Partnerships With Providers,” to improve HPV immunization rates. The grant uses the following methods: (1) providing outreach and training, (2) expanding on educational materials, and (3) forming strong partnerships.27,39,79 The CDC has also developed the “You Are the Key” program, which provides a number of resources for providers and parents (http://www.cdc.gov/vaccines/ed/hpv/index.html). In addition, the AAP has developed an HPV toolkit to educate other health care professionals, discuss HPV vaccination with parents, and make necessary changes in practice to improve HPV vaccination rates (https://www.aap.org/en-us/advocacy-and-policy/aap-health-initiatives/Pages/HPV-Champion-Toolkit.aspx). The National Foundation for Infectious Diseases has developed a monograph available to providers and has established resource pages for parents, adolescents, and providers (http://www.adolescentvaccination.org). Furthermore, the CDC’s Assessment, Feedback, Incentives, and eXchange (AFIX) program is a quality-improvement program that has had significant success in boosting childhood immunization rates. The program consists of an assessment of vaccine coverage and formulation of goals for improvement. AFIX can be conducted via in-person consultation or via webinar. In a randomized controlled trial in North Carolina, AFIX improved immunization rates in 11- through 12-year-old adolescents by 3 to 4 percentage points for Tdap vaccine, by 4 to 5 percentage points for meningococcal vaccine, and by 2 percentage points for HPV vaccine initiation.80 AFIX has highlighted that actual immunization rates in a practice might not mirror clinicians’ perceptions of vaccine administration within their practice. To monitor immunization rates, a practice may periodically audit a sample of their patients.

    Conclusions

    This clinical report summarizes strategies to increase adolescent vaccination rates and addresses specific populations, technologies, and vaccination sites that are important in achieving this goal. Additional strategies to improve immunization rates need to be further explored and evaluated. Appropriate techniques for approaching adolescent patients and their parents in the office to encourage immunizations are important skills for health care providers. The key to increasing immunization rates and decreasing vaccine-preventable diseases among adolescents is to focus on educating adolescents and strengthening health care providers’ recommendations by using all clinical opportunities to assess immunization status and provide needed vaccinations.

    Authors

    Henry H. Bernstein, DO, MHCM, FAAP

    Joseph A. Bocchini Jr, MD, FAAP

    Committee on Infectious Diseases, 2016–2017

    Carrie L. Byington, MD, FAAP, Chairperson

    Yvonne A. Maldonado, MD, FAAP, Vice Chairperson

    Elizabeth D. Barnett, MD, FAAP

    James D. Campbell, MD, FAAP

    H. Dele Davies, MD, MS, MHCM, FAAP

    Ruth Lynfield, MD, FAAP

    Flor M. Munoz, MD, FAAP

    Dawn Nolt, MD, MPH, FAAP

    Ann-Christine Nyquist, MD, MSPH, FAAP

    Sean O’Leary, MD, MPH, FAAP

    Mobeen H. Rathore, MD, FAAP

    Mark H. Sawyer, MD, FAAP

    William J. Steinbach, MD, FAAP

    Tina Q. Tan, MD, FAAP

    Theoklis E. Zaoutis, MD, MSCE, FAAP

    Former Committee Members

    Joseph A. Bocchini Jr, MD, FAAP

    Kathryn M. Edwards, MD, FAAP

    Dennis L. Murray, MD, FAAP

    Gordon E. Schutze, MD, FAAP

    Rodney E. Willoughby, MD, FAAP

    Ex Officio

    David W. Kimberlin, MD, FAAP – Red Book Editor

    Michael T. Brady, MD, FAAP – Red Book Associate Editor

    Mary Anne Jackson, MD, FAAP – Red Book Associate Editor

    Sarah S. Long, MD, FAAP – Red Book Associate Editor

    Henry H. Bernstein, DO, MHCM, FAAP – Red Book Online Associate Editor

    H. Cody Meissner, MD, FAAP – Visual Red Book Associate Editor

    Contributors

    Angie L. Hernandez, MD, FAAP–Department of Pediatrics, Hofstra Northwell School of Medicine

    Julia Bractic, BA – Research Assistant, Cohen Children's Medical Center of New York

    Rebecca J. Schneyer, BA – Research Assistant, Cohen Children's Medical Center of New York

    Catherine Yang, BA – Research Assistant, Cohen Children's Medical Center of New York

    Patriot Yang, BA – Research Assistant, Cohen Children's Medical Center of New York

    Tiffany Yang, BA – Research Assistant, Cohen Children's Medical Center of New York

    Liaisons

    Douglas Campos-Outcalt, MD, MPA – American Academy of Family Physicians

    Amanda C. Cohn, MD, FAAP – Centers for Disease Control and Prevention

    Karen M. Farizo, MD – US Food and Drug Administration

    Marc Fischer, MD, FAAP – Centers for Disease Control and Prevention

    Bruce G. Gellin, MD, MPH – National Vaccine Program Office

    Richard L. Gorman, MD, FAAP – National Institutes of Health

    Natasha Halasa, MD, MPH, FAAP – Pediatric Infectious Diseases Society

    Joan L. Robinson, MD – Canadian Paediatric Society

    Jamie Deseda-Tous, MD – Sociedad Latinoamericana de Infectologia Pediatrica (SLIPE)

    Geoffrey R. Simon, MD, FAAP – Committee on Practice Ambulatory Medicine

    Jeffrey R. Starke, MD, FAAP – American Thoracic Society

    Staff

    Jennifer Frantz, MPH

    Acknowledgment

    We acknowledge the significant contributions of Angie L. Hernandez, MD, FAAP, Department of Pediatrics, Hofstra Northwell School of Medicine.

    Footnotes

    • Address correspondence to Henry H. Bernstein, DO, MHCM, FAAP. E-mail: hbernstein{at}northwell.edu
    • FINANCIAL DISCLOSURE: The authors have indicated they do not have a financial relationship relevant to this article to disclose.

    • FUNDING: No external funding.

    • POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

    • This document is copyrighted and is property of the American Academy of Pediatrics and its Board of Directors. All authors have filed conflict of interest statements with the American Academy of Pediatrics. Any conflicts have been resolved through a process approved by the Board of Directors. The American Academy of Pediatrics has neither solicited nor accepted any commercial involvement in the development of the content of this publication.

    • Clinical reports from the American Academy of Pediatrics benefit from expertise and resources of liaisons and internal (AAP) and external reviewers. However, clinical reports from the American Academy of Pediatrics may not reflect the views of the liaisons or the organizations or government agencies that they represent.

    • The guidance in this report does not indicate an exclusive course of treatment or serve as a standard of medical care. Variations, taking into account individual circumstances, may be appropriate.

    • All clinical reports from the American Academy of Pediatrics automatically expire 5 years after publication unless reaffirmed, revised, or retired at or before that time.

    References

    1. ↵
      1. Committee on Practice and Ambulatory Medicine
      2. Bright Futures Periodicity Schedule Workgroup
      . 2016 recommendations for pediatric preventive health care. Pediatrics. 2016;137(1):e20153908
      OpenUrl
    2. ↵
      1. Schneyer RJ,
      2. Yang C,
      3. Bocchini JA Jr
      . Immunizing adolescents: a selected review of recent literature and US recommendations. Curr Opin Pediatr. 2015;27(3):405–417pmid:25888153
      OpenUrlPubMed
    3. ↵
      Healthy People 2020. Adolescent health. US Department of Health and Human Services; 2014. Available at: https://www.healthypeople.gov/2020/data-search/Search-the-Data. Accessed June 20, 2016
    4. ↵
      1. Lau JS,
      2. Adams SH,
      3. Boscardin WJ,
      4. Irwin CE Jr
      . Young adults’ health care utilization and expenditures prior to the Affordable Care Act. J Adolesc Health. 2014;54(6):663–671pmid:24702839
      OpenUrlCrossRefPubMed
    5. ↵
      1. Rand CM,
      2. Shone LP,
      3. Albertin C,
      4. Auinger P,
      5. Klein JD,
      6. Szilagyi PG
      . National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines. Arch Pediatr Adolesc Med. 2007;161(3):252–259pmid:17339506
      OpenUrlCrossRefPubMed
    6. ↵
      1. Ziv A,
      2. Boulet JR,
      3. Slap GB
      . Utilization of physician offices by adolescents in the United States. Pediatrics. 1999;104(1 pt 1):35–42pmid:10390257
      OpenUrlAbstract/FREE Full Text
    7. ↵
      1. Kharbanda EO,
      2. Stockwell MS,
      3. Colgrove J,
      4. Natarajan K,
      5. Rickert VI
      . Changes in Tdap and MCV4 vaccine coverage following enactment of a statewide requirement of Tdap vaccination for entry into sixth grade. Am J Public Health. 2010;100(9):1635–1640pmid:20634463
      OpenUrlCrossRefPubMed
    8. ↵
      1. Committee on Infectious Diseases
      . Recommended childhood and adolescent immunization schedule—United States, 2016. Pediatrics. 2016;137(3):e20154531pmid:26908698
      OpenUrlFREE Full Text
    9. ↵
      1. Dorell C,
      2. Yankey D,
      3. Strasser S
      . Parent-reported reasons for nonreceipt of recommended adolescent vaccinations, national immunization survey: teen, 2009. Clin Pediatr (Phila). 2011;50(12):1116–1124pmid:21856964
      OpenUrlAbstract/FREE Full Text
    10. ↵
      1. Stokley S,
      2. Jeyarajah J,
      3. Yankey D, et al; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention
      . Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014—United States. MMWR Morb Mortal Wkly Rep. 2014;63(29):620–624pmid:25055185
      OpenUrlPubMed
    11. ↵
      1. Humiston SG,
      2. Serwint JR,
      3. Szilagyi PG, et al
      . Increasing adolescent immunization rates in primary care: strategies physicians use and would consider implementing. Clin Pediatr (Phila). 2013;52(8):710–720pmid:23580625
      OpenUrlAbstract/FREE Full Text
    12. ↵
      1. Fiks AG,
      2. Grundmeier RW,
      3. Mayne S, et al
      . Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt. Pediatrics. 2013;131(6):1114–1124pmid:23650297
      OpenUrlAbstract/FREE Full Text
    13. ↵
      1. Sittig DF,
      2. Teich JM,
      3. Osheroff JA,
      4. Singh H
      . Improving clinical quality indicators through electronic health records: it takes more than just a reminder. Pediatrics. 2009;124(1):375–377pmid:19564321
      OpenUrlFREE Full Text
    14. ↵
      1. Edwards KM,
      2. Hackell JM; Committee on Infectious Diseases; Committee on Practice and Ambulatory Medicine
      . Clinical report: countering vaccine hesitancy. Pediatrics. 2016;138(3):e20162146pmid:27573088
      OpenUrlAbstract/FREE Full Text
    15. ↵
      1. Opel DJ,
      2. Heritage J,
      3. Taylor JA, et al
      . The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics. 2013;132(6):1037–1046pmid:24190677
      OpenUrlAbstract/FREE Full Text
    16. ↵
      1. Diekema DS; Committee on Bioethics
      . Responding to parental refusals of immunization of children. Pediatrics. 2005;115(5):1428–1431. Reaffirmed May 2013
      OpenUrlAbstract/FREE Full Text
    17. ↵
      1. Greenfield LS,
      2. Page LC,
      3. Kay M,
      4. Li-Vollmer M,
      5. Breuner CC,
      6. Duchin JS
      . Strategies for increasing adolescent immunizations in diverse ethnic communities. J Adolesc Health. 2015;56(5 suppl):S47–S53pmid:25863555
      OpenUrlPubMed
    18. ↵
      1. Leask J,
      2. Kinnersley P,
      3. Jackson C,
      4. Cheater F,
      5. Bedford H,
      6. Rowles G
      . Communicating with parents about vaccination: a framework for health professionals. BMC Pediatr. 2012;12:154pmid:22998654
      OpenUrlCrossRefPubMed
    19. ↵
      1. Henrikson NB,
      2. Opel DJ,
      3. Grothaus L, et al
      . Physician communication training and parental vaccine hesitancy: a randomized trial. Pediatrics. 2015;136(1):70–79pmid:26034240
      OpenUrlAbstract/FREE Full Text
    20. ↵
      1. Middleman AB,
      2. Rosenthal SL,
      3. Rickert VI,
      4. Neinstein L,
      5. Fishbein DB,
      6. D’Angelo L; Society for Adolescent Medicine
      . Adolescent immunizations: a position paper of the Society for Adolescent Medicine. J Adolesc Health. 2006;38(3):321–327pmid:16521332
      OpenUrlCrossRefPubMed
    21. ↵
      1. Gust DA,
      2. Darling N,
      3. Kennedy A,
      4. Schwartz B
      . Parents with doubts about vaccines: which vaccines and reasons why. Pediatrics. 2008;122(4):718–725pmid:18829793
      OpenUrlAbstract/FREE Full Text
    22. ↵
      1. Sanders RA
      . Adolescent psychosocial, social, and cognitive development. Pediatr Rev. 2013;34(8):354–358; quiz: 358–359pmid:23908362
      OpenUrlFREE Full Text
    23. ↵
      1. Rollnick S,
      2. Miller WR,
      3. Butler CC
      . Motivational Interviewing in Health Care. New York, NY: The Guilford Press; 2008
    24. ↵
      1. Miller WR,
      2. Rollnick S
      . Ten things that motivational interviewing is not. Behav Cogn Psychother. 2009;37(2):129–140pmid:19364414
      OpenUrlCrossRefPubMed
    25. ↵
      1. Halperin S
      . How to manage parents unsure about immunization. Can J CME. 2000;12(1):62–75
      OpenUrl
    26. ↵
      1. Gust D,
      2. Brown C,
      3. Sheedy K,
      4. Hibbs B,
      5. Weaver D,
      6. Nowak G
      . Immunization attitudes and beliefs among parents: beyond a dichotomous perspective. Am J Health Behav. 2005;29(1):81–92pmid:15604052
      OpenUrlCrossRefPubMed
    27. ↵
      1. Benin AL,
      2. Wisler-Scher DJ,
      3. Colson E,
      4. Shapiro ED,
      5. Holmboe ES
      . Qualitative analysis of mothers’ decision-making about vaccines for infants: the importance of trust. Pediatrics. 2006;117(5):1532–1541pmid:16651306
      OpenUrlAbstract/FREE Full Text
    28. ↵
      1. Downs JS,
      2. de Bruin WB,
      3. Fischhoff B
      . Parents’ vaccination comprehension and decisions. Vaccine. 2008;26(12):1595–1607pmid:18295940
      OpenUrlCrossRefPubMed
    29. ↵
      1. American Academy of Pediatrics
      . Immunization Training Guide. Available at: https://www.aap.org/en-us/advocacy-and-policy/aap-health-initiatives/immunization/Pages/training-guide.aspx. Accessed June 20, 2016
    30. ↵
      1. Bratic JS,
      2. Seyferth ER,
      3. Bocchini JA Jr
      . Update on barriers to human papillomavirus vaccination and effective strategies to promote vaccine acceptance. Curr Opin Pediatr. 2016;28(3):407–412pmid:27093354
      OpenUrlPubMed
    31. ↵
      1. Meites E,
      2. Kempe A,
      3. Markowitz LE
      . Use of a 2-dose schedule for human papillomavirus vaccination - Updated recommendation of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2016;65:1405–1408
      OpenUrl
    32. ↵
      1. Perkins RB,
      2. Clark JA,
      3. Apte G, et al
      . Missed opportunities for HPV vaccination in adolescent girls: a qualitative study. Pediatrics. 2014;134(3). Available at: www.pediatrics.org/cgi/content/full/134/3/e666pmid:25136036
      OpenUrlAbstract/FREE Full Text
    33. ↵
      1. Iversen OE,
      2. Miranda MJ,
      3. Ulied A, et al
      . Immunogenicity of the 9-valent HPV vaccine using 2-dose regimens in girls and boys vs a 3-dose regimen in women. JAMA. 2016;316(22):2411–2421pmid:27893068
      OpenUrlPubMed
    34. ↵
      1. Brewer NT,
      2. Hall ME,
      3. Mato TL, et al
      . Announcements versus conversations to improve HPV vaccination coverage: a randomized control trial. Pediatrics. 2017;139(1):e20161764
      OpenUrlAbstract/FREE Full Text
    35. ↵
      1. Hull PC,
      2. Williams EA,
      3. Khabele D,
      4. Dean C,
      5. Bond B,
      6. Sanderson M
      . HPV vaccine use among African American girls: qualitative formative research using a participatory social marketing approach. Gynecol Oncol. 2014;132(suppl 1):S13–S20pmid:24491412
      OpenUrlCrossRefPubMed
    36. ↵
      1. Global Advisory Committee on Vaccine Safety
      . Statement on safety of HPV vaccines. World Health Organization; December 2015. Available at: www.who.int/vaccine_safety/committee/GACVS_HPV_statement_17Dec2015.pdf. Accessed June 20, 2016
    37. ↵
      1. Wong CA,
      2. Taylor JA,
      3. Wright JA,
      4. Opel DJ,
      5. Katzenellenbogen RA
      . Missed opportunities for adolescent vaccination, 2006-2011. J Adolesc Health. 2013;53(4):492–497pmid:23809613
      OpenUrlCrossRefPubMed
    38. ↵
      1. Oster NV,
      2. McPhillips-Tangum CA,
      3. Averhoff F,
      4. Howell K
      . Barriers to adolescent immunization: a survey of family physicians and pediatricians. J Am Board Fam Pract. 2005;18(1):13–19pmid:15709059
      OpenUrlAbstract/FREE Full Text
    39. ↵
      1. Reiter PL,
      2. McRee AL
      . Correlates of receiving recommended adolescent vaccines among youth with special health care needs: findings from a statewide survey. Vaccine. 2016;34(27):3125–3131pmid:27129424
      OpenUrlPubMed
    40. ↵
      1. Halpern-Felsher BL,
      2. Ozer EM,
      3. Millstein SG, et al
      . Preventive services in a health maintenance organization: how well do pediatricians screen and educate adolescent patients? Arch Pediatr Adolesc Med. 2000;154(2):173–179pmid:10665605
      OpenUrlCrossRefPubMed
    41. ↵
      1. Szilagyi PG,
      2. Rand CM,
      3. McLaurin J, et al; Working Group on Adolescent Vaccination in the Medical Home
      . Delivering adolescent vaccinations in the medical home: a new era? Pediatrics. 2008;121(suppl 1):S15–S24pmid:18174317
      OpenUrlAbstract/FREE Full Text
    42. ↵
      1. Fiks AG,
      2. Grundmeier RW,
      3. Biggs LM,
      4. Localio AR,
      5. Alessandrini EA
      . Impact of clinical alerts within an electronic health record on routine childhood immunization in an urban pediatric population. Pediatrics. 2007;120(4):707–714pmid:17908756
      OpenUrlAbstract/FREE Full Text
      1. Fiks AG,
      2. Hunter KF,
      3. Localio AR, et al
      . Impact of electronic health record-based alerts on influenza vaccination for children with asthma. Pediatrics. 2009;124(1):159–169pmid:19564296
      OpenUrlAbstract/FREE Full Text
    43. ↵
      1. Merkel PA,
      2. Caputo GC
      . Evaluation of a simple office-based strategy for increasing influenza vaccine administration and the effect of differing reimbursement plans on the patient acceptance rate. J Gen Intern Med. 1994;9(12):679–683pmid:7876950
      OpenUrlPubMed
    44. ↵
      1. Dempsey AF,
      2. Maertens J,
      3. Beaty BL,
      4. O’Leary ST
      . Understanding how different recruitment strategies impact parent engagement with an iPad-based intervention to provide personalized information about adolescent vaccines. J Adolesc Health. 2015;56(5 suppl):S7–S13pmid:25863557
      OpenUrlCrossRefPubMed
    45. ↵
      1. Schaffer SJ,
      2. Humiston SG,
      3. Shone LP,
      4. Averhoff FM,
      5. Szilagyi PG
      . Adolescent immunization practices: a national survey of US physicians. Arch Pediatr Adolesc Med. 2001;155(5):566–571pmid:11343499
      OpenUrlCrossRefPubMed
    46. ↵
      1. Bar-Shain DS,
      2. Stager MM,
      3. Runkle AP,
      4. Leon JB,
      5. Kaelber DC
      . Direct messaging to parents/guardians to improve adolescent immunizations. J Adolesc Health. 2015;56(5 suppl):S21–S26pmid:25863550
      OpenUrlPubMed
    47. ↵
      1. Szilagyi PG,
      2. Albertin C,
      3. Humiston SG, et al
      . A randomized trial of the effect of centralized reminder/recall on immunizations and preventive care visits for adolescents. Acad Pediatr. 2013;13(3):204–213pmid:23510607
      OpenUrlCrossRefPubMed
    48. ↵
      1. Rand CM,
      2. Brill H,
      3. Albertin C, et al
      . Effectiveness of centralized text message reminders on human papillomavirus immunization coverage for publicly insured adolescents. J Adolesc Health. 2015;56(5 suppl):S17–S20pmid:25863549
      OpenUrlPubMed
    49. ↵
      1. Morris J,
      2. Wang W,
      3. Wang L,
      4. Peddecord KM,
      5. Sawyer MH
      . Comparison of reminder methods in selected adolescents with records in an immunization registry. J Adolesc Health. 2015;56(5 suppl):S27–S32pmid:25863551
      OpenUrlPubMed
    50. ↵
      1. Stockwell MS,
      2. Kharbanda EO,
      3. Martinez RA,
      4. Vargas CY,
      5. Vawdrey DK,
      6. Camargo S
      . Effect of a text messaging intervention on influenza vaccination in an urban, low-income pediatric and adolescent population: a randomized controlled trial. JAMA. 2012;307(16):1702–1708pmid:22535855
      OpenUrlCrossRefPubMed
    51. ↵
      1. Matheson EC,
      2. Derouin A,
      3. Gagliano M,
      4. Thompson JA,
      5. Blood-Siegfried J
      . Increasing HPV vaccination series completion rates via text message reminders. J Pediatr Health Care. 2014;28(4):e35–e39pmid:24200295
      OpenUrlCrossRefPubMed
    52. ↵
      1. Szilagyi PG,
      2. Humiston SG,
      3. Gallivan S,
      4. Albertin C,
      5. Sandler M,
      6. Blumkin A
      . Effectiveness of a citywide patient immunization navigator program on improving adolescent immunizations and preventive care visit rates. Arch Pediatr Adolesc Med. 2011;165(6):547–553pmid:21646588
      OpenUrlCrossRefPubMed
    53. ↵
      1. Federico SG,
      2. Abrams L,
      3. Everhart RM,
      4. Melinkovich P,
      5. Hambidge SJ
      . Addressing adolescent immunization disparities: a retrospective analysis of school-based health center immunization delivery. Am J Public Health. 2010;100(9):1630–1634pmid:20634466
      OpenUrlCrossRefPubMed
      1. Golden SD,
      2. Moracco KE,
      3. Feld AL,
      4. Turner KL,
      5. DeFrank JT,
      6. Brewer NT
      . Process evaluation of an intervention to increase provision of adolescent vaccines at school health centers. Health Educ Behav. 2014;41(6):625–632pmid:24786792
      OpenUrlAbstract/FREE Full Text
      1. Kempe A,
      2. Barrow J,
      3. Stokley S, et al
      . Effectiveness and cost of immunization recall at school-based health centers. Pediatrics. 2012;129(6). Available at: www.pediatrics.org/cgi/content/full/129/6/e1446pmid:22566414
      OpenUrlAbstract/FREE Full Text
    54. ↵
      1. Daley MF,
      2. Curtis CR,
      3. Pyrzanowski J, et al
      . Adolescent immunization delivery in school-based health centers: a national survey. J Adolesc Health. 2009;45(5):445–452pmid:19837350
      OpenUrlCrossRefPubMed
    55. ↵
      1. Council on School Health
      . School-based health centers and pediatric practice. Pediatrics. 2012;129(2):387–393pmid:22291117
      OpenUrlAbstract/FREE Full Text
    56. ↵
      1. Dempsey AF,
      2. Schaffer S
      . Middle- and high-school health education regarding adolescent vaccines and human papillomavirus. Vaccine. 2010;28(44):7179–7183pmid:20801244
      OpenUrlPubMed
    57. ↵
      1. Lancman H,
      2. Pastore DR,
      3. Steed N,
      4. Maresca A
      . Adolescent hepatitis B vaccination: comparison among 2 high school-based health centers and an adolescent clinic. Arch Pediatr Adolesc Med. 2000;154(11):1085–1088pmid:11074847
      OpenUrlCrossRefPubMed
    58. ↵
      1. Pyrzanowski J,
      2. Curtis CR,
      3. Crane LA, et al
      . Adolescents’ perspectives on vaccination outside the traditional medical home: a survey of urban middle and high school students. Clin Pediatr (Phila). 2013;52(4):329–337pmid:23406720
      OpenUrlAbstract/FREE Full Text
    59. ↵
      1. Clevenger LM,
      2. Pyrzanowski J,
      3. Curtis CR, et al
      . Parents’ acceptance of adolescent immunizations outside of the traditional medical home. J Adolesc Health. 2011;49(2):133–140pmid:21783044
      OpenUrlCrossRefPubMed
    60. ↵
      1. Klein JD,
      2. McNulty M,
      3. Flatau CN
      . Adolescents’ access to care: teenagers’ self-reported use of services and perceived access to confidential care. Arch Pediatr Adolesc Med. 1998;152(7):676–682pmid:9667540
      OpenUrlCrossRefPubMed
    61. ↵
      1. Middleman AB
      . Coordinating the delivery of vaccinations and other preventive health care recommendations for adolescents. Prev Med. 2011;53(suppl 1):S22–S28pmid:21962467
      OpenUrlCrossRefPubMed
    62. ↵
      1. Strickland BB,
      2. Jones JR,
      3. Ghandour RM,
      4. Kogan MD,
      5. Newacheck PW
      . The medical home: health care access and impact for children and youth in the United States. Pediatrics. 2011;127(4):604–611pmid:21402643
      OpenUrlAbstract/FREE Full Text
    63. ↵
      1. Stubbs BW,
      2. Panozzo CA,
      3. Moss JL,
      4. Reiter PL,
      5. Whitesell DH,
      6. Brewer NT
      . Evaluation of an intervention providing HPV vaccine in schools. Am J Health Behav. 2014;38(1):92–102pmid:24034684
      OpenUrlCrossRefPubMed
    64. ↵
      1. Shlay JC,
      2. Rodgers S,
      3. Lyons J,
      4. Romero S,
      5. Vogt TM,
      6. McCormick EV
      . Implementing a school-located vaccination program in Denver public schools. J Sch Health. 2015;85(8):536–543pmid:26149309
      OpenUrlPubMed
    65. ↵
      1. Daley MF,
      2. Kempe A,
      3. Pyrzanowski J, et al
      . School-located vaccination of adolescents with insurance billing: cost, reimbursement, and vaccination outcomes. J Adolesc Health. 2014;54(3):282–288pmid:24560036
      OpenUrlCrossRefPubMed
    66. ↵
      1. Tran CH,
      2. Brew J,
      3. Johnson N, et al
      . Sustainability of school-located influenza vaccination programs in Florida. Vaccine. 2016;34(24):2737–2744pmid:27126875
      OpenUrlPubMed
    67. ↵
      1. Peterson RM,
      2. Cook C,
      3. Yerxa ME,
      4. Marshall JH,
      5. Pulos E,
      6. Rollosson MP
      . Improving immunization coverage in a rural school district in Pierce County, Washington. J Sch Nurs. 2012;28(5):352–357pmid:22550163
      OpenUrlAbstract/FREE Full Text
    68. ↵
      National Association of School Nurses; National Association of County and City Health Officials; Association of State and Territorial Health Officials. School-located vaccination clinics. Presented at the NASN, NACCHO, ASTHO Summit. Meeting summary. November 16–17, 2010;1–42. Available at: www.astho.org/Immunization/School-Located-Vaccination-Clinics-Meeting-Summary/. Accessed June 20, 2016
    69. ↵
      1. Caskey RN,
      2. Macario E,
      3. Johnson DC,
      4. Hamlish T,
      5. Alexander KA
      . A school-located vaccination adolescent pilot initiative in Chicago: lessons learned. J Pediatric Infect Dis Soc. 2013;2(3):198–204pmid:24009983
      OpenUrlAbstract/FREE Full Text
    70. ↵
      1. Averhoff F,
      2. Linton L,
      3. Peddecord KM,
      4. Edwards C,
      5. Wang W,
      6. Fishbein D
      . A middle school immunization law rapidly and substantially increases immunization coverage among adolescents. Am J Public Health. 2004;94(6):978–984pmid:15249302
      OpenUrlCrossRefPubMed
    71. ↵
      1. Wilson TR,
      2. Fishbein DB,
      3. Ellis PA,
      4. Edlavitch SA
      . The impact of a school entry law on adolescent immunization rates. J Adolesc Health. 2005;37(6):511–516pmid:16310129
      OpenUrlCrossRefPubMed
    72. ↵
      1. Bugenske E,
      2. Stokley S,
      3. Kennedy A,
      4. Dorell C
      . Middle school vaccination requirements and adolescent vaccination coverage. Pediatrics. 2012;129(6):1056–1063pmid:22566425
      OpenUrlAbstract/FREE Full Text
    73. ↵
      1. National Vaccine Advisory Committee
      . Mandates for adolescent immunizations: recommendations from the National Vaccine Advisory Committee. Am J Prev Med. 2008;35(2):145–151pmid:18617083
      OpenUrlCrossRefPubMed
    74. ↵
      1. Dempsey AF,
      2. Schaffer SE
      . Human papillomavirus vaccination rates and state mandates for tetanus-containing vaccines. Prev Med. 2011;52(3–4):268–269pmid:21195727
      OpenUrlPubMed
    75. ↵
      1. Reagan-Steiner S,
      2. Yankey D,
      3. Jeyarajah J, et al
      . National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2014. MMWR Wkly Rep. 2015;64(29):784–792
      OpenUrl
    76. ↵
      1. American Academy of Pediatrics
      . Grant will support QI methods to improve HPV vaccination. AAP News. 2014;35(10):26
      OpenUrlFREE Full Text
    77. ↵
      1. Gilkey MB,
      2. Dayton AM,
      3. Moss JL, et al
      . Increasing provision of adolescent vaccines in primary care: a randomized controlled trial. Pediatrics. 2014;134(2). Available at: www.pediatrics.org/cgi/content/full/134/2/e346pmid:25002671
      OpenUrlAbstract/FREE Full Text
    • Copyright © 2017 by the American Academy of Pediatrics
    PreviousNext
    Back to top

    Advertising Disclaimer »

    In this issue

    Pediatrics
    Vol. 139, Issue 3
    1 Mar 2017
    • Table of Contents
    • Index by author
    View this article with LENS
    PreviousNext
    Email Article

    Thank you for your interest in spreading the word on American Academy of Pediatrics.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Practical Approaches to Optimize Adolescent Immunization
    (Your Name) has sent you a message from American Academy of Pediatrics
    (Your Name) thought you would like to see the American Academy of Pediatrics web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Request Permissions
    Article Alerts
    Log in
    You will be redirected to aap.org to login or to create your account.
    Or Sign In to Email Alerts with your Email Address
    Citation Tools
    Practical Approaches to Optimize Adolescent Immunization
    Henry H. Bernstein, Joseph A. Bocchini, COMMITTEE ON INFECTIOUS DISEASES
    Pediatrics Mar 2017, 139 (3) e20164187; DOI: 10.1542/peds.2016-4187

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Practical Approaches to Optimize Adolescent Immunization
    Henry H. Bernstein, Joseph A. Bocchini, COMMITTEE ON INFECTIOUS DISEASES
    Pediatrics Mar 2017, 139 (3) e20164187; DOI: 10.1542/peds.2016-4187
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Print
    Download PDF
    Insight Alerts
    • Table of Contents

    Jump to section

    • Article
      • Abstract
      • Introduction
      • Strategies for Improving Adolescent Vaccination Rates
      • Conclusions
      • Authors
      • Committee on Infectious Diseases, 2016–2017
      • Former Committee Members
      • Ex Officio
      • Contributors
      • Liaisons
      • Staff
      • Acknowledgment
      • Footnotes
      • References
    • Figures & Data
    • Supplemental
    • Info & Metrics
    • Comments

    Related Articles

    • PubMed
    • Google Scholar

    Cited By...

    • Pediatric Inpatient Immunizations: A Literature Review
    • Parent-Provider Communication of HPV Vaccine Hesitancy
    • Google Scholar

    More in this TOC Section

    • Maltreatment of Children With Disabilities
    • AAP Publications Reaffirmed or Retired
    • Caring for American Indian and Alaska Native Children and Adolescents
    Show more From the American Academy of Pediatrics

    Similar Articles

    Subjects

    • Current Policy
    • Infectious Disease
      • Infectious Disease
      • Vaccine/Immunization
    • AAP Policy Collections by Authoring Entities
      • Committee on Infectious Diseases
    • Journal Info
    • Editorial Board
    • Editorial Policies
    • Overview
    • Licensing Information
    • Authors/Reviewers
    • Author Guidelines
    • Submit My Manuscript
    • Open Access
    • Reviewer Guidelines
    • Librarians
    • Institutional Subscriptions
    • Usage Stats
    • Support
    • Contact Us
    • Subscribe
    • Resources
    • Media Kit
    • About
    • International Access
    • Terms of Use
    • Privacy Statement
    • FAQ
    • AAP.org
    • shopAAP
    • Follow American Academy of Pediatrics on Instagram
    • Visit American Academy of Pediatrics on Facebook
    • Follow American Academy of Pediatrics on Twitter
    • Follow American Academy of Pediatrics on Youtube
    • RSS
    American Academy of Pediatrics

    © 2021 American Academy of Pediatrics